- Home
- ATHA vs CCTG Comparison
ATHA vs CCTG Comparison
Compare ATHA & CCTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- CCTG
- Stock Information
- Founded
- ATHA 2011
- CCTG 1993
- Country
- ATHA United States
- CCTG Hong Kong
- Employees
- ATHA N/A
- CCTG N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- CCTG
- Sector
- ATHA Health Care
- CCTG
- Exchange
- ATHA Nasdaq
- CCTG Nasdaq
- Market Cap
- ATHA 22.3M
- CCTG 18.1M
- IPO Year
- ATHA 2020
- CCTG 2024
- Fundamental
- Price
- ATHA $0.54
- CCTG $1.50
- Analyst Decision
- ATHA Buy
- CCTG
- Analyst Count
- ATHA 4
- CCTG 0
- Target Price
- ATHA $11.25
- CCTG N/A
- AVG Volume (30 Days)
- ATHA 325.4K
- CCTG 19.5K
- Earning Date
- ATHA 11-07-2024
- CCTG 07-22-2024
- Dividend Yield
- ATHA N/A
- CCTG N/A
- EPS Growth
- ATHA N/A
- CCTG N/A
- EPS
- ATHA N/A
- CCTG N/A
- Revenue
- ATHA N/A
- CCTG $14,748,551.00
- Revenue This Year
- ATHA N/A
- CCTG N/A
- Revenue Next Year
- ATHA N/A
- CCTG N/A
- P/E Ratio
- ATHA N/A
- CCTG N/A
- Revenue Growth
- ATHA N/A
- CCTG N/A
- 52 Week Low
- ATHA $0.41
- CCTG $1.20
- 52 Week High
- ATHA $4.30
- CCTG $30.00
- Technical
- Relative Strength Index (RSI)
- ATHA 36.91
- CCTG 35.47
- Support Level
- ATHA $0.56
- CCTG $1.59
- Resistance Level
- ATHA $0.61
- CCTG $1.69
- Average True Range (ATR)
- ATHA 0.04
- CCTG 0.10
- MACD
- ATHA -0.01
- CCTG -0.02
- Stochastic Oscillator
- ATHA 8.45
- CCTG 0.00
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About CCTG CCSC Technology International Holdings Limited
CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas and Asia.